Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection

PLoS Medicine

Volumn 10, Issue 11, 2013, Pages

  Mejias, Asuncion ^a   Dimo, Blerta ^a   Suarez, Nicolas M ^a   Garcia, Carla ^b   Suarez Arrabal, M Carmen ^a   Jartti, Tuomas ^c   Blankenship, Derek ^d   Jordan Villegas, Alejandro ^b   Ardura, Monica I ^a   Xu, Zhaohui ^e   Banchereau, Jacques ^e   Chaussabel, Damien ^e,f   Ramilo, Octavio ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d BAYLOR RESEARCH INSTITUTE   (United States)

^e BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^f BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AGE; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; INFANT; INFLUENZA; INNATE IMMUNITY; INTENSIVE CARE UNIT; MALE; MICROARRAY ANALYSIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RNA FINGERPRINTING; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FINLAND; HUMANS; INFANT; LENGTH OF STAY; MALE; MICROARRAY ANALYSIS; ORTHOMYXOVIRIDAE; OXYGEN; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; QUALITATIVE RESEARCH; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS; RNA; SEVERITY OF ILLNESS INDEX; TRANSCRIPTOME; UNITED STATES;

EID: 84888990746     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001549     Document Type: Article

References (38)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, (2005) WHO estimates of the causes of death in children. Lancet 365: 1147-1152.
2. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, et al. (1997) Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet 349: 1191-1197.
3. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341-1348.
4. Madhi SA, Klugman KP, (2004) A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10: 811-813.
5. Berkley JA, Munywoki P, Ngama M, Kazungu S, Abwao J, et al. (2010) Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 303: 2051-2057.
6. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, et al. (2009) The burden of respiratory syncytial virus infection in young children. N Engl J Med 360: 588-598.
7. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555.
8. Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, et al. (2010) Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics 126: e1453-e1460.
9. Nolte FS, Marshall DJ, Rasberry C, Schievelbein S, Banks GG, et al. (2007) MultiCode-PLx system for multiplexed detection of seventeen respiratory viruses. J Clin Microbiol 45: 2779-2786.
10. Garcia C, Soriano-Fallas A, Lozano J, Leos N, Gomez AM, et al. (2012) Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J 31: 86-89.
11. Mella C, Suarez-Arrabal MC, Lopez S, Stephens J, Fernandez S, et al. (2013) Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 207: 564-573.
12. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, et al. (1983) Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 71: 13-18.
13. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
14. Banchereau R, Jordan-Villegas A, Ardura M, Mejias A, Baldwin N, et al. (2012) Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 7: e34390 doi:10.1371/journal.pone.0034390.
15. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066-2077.
16. Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, et al. (2007) Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 204: 2131-2144.
17. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
18. Wittkowski KM, Song T, (2010) Nonparametric methods for molecular biology. Methods Mol Biol 620: 105-153.
19. Wittkowski KM, Lee E, Nussbaum R, Chamian FN, Krueger JG, (2004) Combining several ordinal measures in clinical studies. Stat Med 23: 1579-1592.
20. Ardura MI, Banchereau R, Mejias A, Di Pucchio T, Glaser C, et al. (2009) Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS ONE 4: e5446 doi:10.1371/journal.pone.0005446.
21. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150-164.
22. Obermoser G, Presnell S, Domico K, Xu H, Wang Y, et al. (2013) Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38: 831-844.
23. Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, et al. (2009) Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 10: R127.
24. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, et al. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28: 827-838.
25. Huang YC, Li Z, Hyseni X, Schmitt M, Devlin RB, et al. (2008) Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line. Genomic Med 2: 113-125.
26. Martinez I, Lombardia L, Garcia-Barreno B, Dominguez O, Melero JA, (2007) Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J Gen Virol 88: 570-581.
27. Ioannidis I, McNally B, Willette M, Peeples ME, Chaussabel D, et al. (2012) Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J Virol 86: 5422-5436.
28. Bhoj VG, Sun Q, Bhoj EJ, Somers C, Chen X, et al. (2008) MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci U S A 105: 14046-14051.
29. Janssen R, Pennings J, Hodemaekers H, Buisman A, van Oosten M, et al. (2007) Host transcription profiles upon primary respiratory syncytial virus infection. J Virol 81: 5958-5967.
30. Pennings JL, Schuurhof A, Hodemaekers HM, Buisman A, de Rond LC, et al. (2011) Systemic signature of the lung response to respiratory syncytial virus infection. PLoS ONE 6: e21461 doi:10.1371/journal.pone.0021461.
31. Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B, (2007) Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis 196: 394-404.
32. Fjaerli HO, Bukholm G, Krog A, Skjaeret C, Holden M, et al. (2006) Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. BMC Infect Dis 6: 175.
33. Bucasas KL, Mian AI, Demmler-Harrison GJ, Caviness AC, Piedra PA, et al. (2013) Global gene expression profiling in infants with acute respiratory syncytial virus broncholitis demonstrates systemic activation of interferon signaling networks. Pediatr Infect Dis J 32: e68-e76.
34. Smith SB, Dampier W, Tozeren A, Brown JR, Magid-Slav M, (2012) Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis. PLoS ONE 7: e33174 doi:10.1371/journal.pone.0033174.
35. Zaas AK, Chen M, Varkey J, Veldman T, Hero AO 3rd, et al. (2009) Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6: 207-217.
36. Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, et al. (2005) A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol 75: 282-289.
37. Gill MA, Long K, Kwon T, Muniz L, Mejias A, et al. (2008) Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection. J Infect Dis 198: 1667-1676.
38. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126-1136.